U.S. FDA advisers back authorization of Moderna COVID vaccine for ages 6-17

(Reuters) – Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc’s COVID-19 vaccine for children and teens aged 6 to 17 years of age.

(Reporting by Manas Mishra in Bengaluru; Editing by Chris Reese)